Core Viewpoint - The article highlights the recent financial performance and market activity of Jiangsu Panyam Micro透 Technology Co., Ltd., indicating a positive trend in financing and investment activities [1]. Financial Performance - Last week, Jiangsu Panyam Micro透 had a net financing inflow of 14.84 million RMB, ranking 487th in the market [1]. - The total financing amount for the week was 108 million RMB, while the repayment amount was 93.19 million RMB [1]. Market Activity - Over the past 5 days, the main capital inflow into Jiangsu Panyam Micro透 was 26.51 million RMB, with a price increase of 3.04% [1]. - In the last 10 days, the main capital inflow was 36.84 million RMB, with a price increase of 2.65% [1]. Company Overview - Jiangsu Panyam Micro透 Technology Co., Ltd. was established in 1995 and is located in Changzhou, primarily engaged in the manufacturing of chemical raw materials and products [1]. - The company has a registered capital of 91 million RMB and a paid-in capital of 45 million RMB [1]. - The legal representative of the company is Zhang Yun [1]. Investment and Intellectual Property - The company has made investments in 9 enterprises and participated in 38 bidding projects [1]. - In terms of intellectual property, Jiangsu Panyam Micro透 holds 33 trademarks and 355 patents, along with 19 administrative licenses [1].

7月30日数据显示，南卫股份主力资金净流出692.19万元，占流通市值的0.36%。 截至2025年7月30日15时，南卫股份股价报6.64元，较前一交易日下跌0.11元，跌幅1.63%。当日开盘价 为6.85元，最高触及6.88元，最低下探至6.58元，成交量为79879手，成交金额达0.53亿元。 南卫股份主要从事医疗器械的研发、生产和销售，产品涵盖医用敷料、防护用品等多个领域。公司所属 板块包括医疗器械、江苏板块等概念。 根据公开信息显示，南卫股份在2025年半年度业绩预告中出现净利润首次亏损情况。这一情况与医药行 业整体表现相关，在已发布半年度业绩预告的107家医药企业中，有近20家企业出现净利首亏。 风险提示：以上内容仅供参考，不构成任何投资建议。市场有风险，投资需谨慎。 ...